Citation only
via Europe PMC
Bridging Trauma and Parkinson's Disease: Mechanisms, Models, and Biomarkers of Post-Traumatic Parkinsonism.
Satyaprakash SA, Gupta NK, Singh S, Gupta RK, Singh SP.
Journal of neurotrauma · 2026
Abstract
One of the most prevalent neurodegenerative diseases, Parkinson's disease (PD), is generally discussed in terms of aging, genetic predisposition, and environmental exposures. Nonetheless, there is growing evidence that both isolated severe traumatic events and repetitive mild traumatic brain injury may play a significant role in the development of parkinsonian features. This trauma-associated condition, known as Post-Traumatic Parkinsonism Syndrome (PTPS), is becoming more widely acknowledged as a clinically significant but underdiagnosed illness. The differences between PTPS and conditions like chronic traumatic encephalopathy (CTE) are often blurred because, in contrast to idiopathic PD, PTPS typically manifests after a specified latency period following head injury and is often accompanied by overlapping symptoms of cognitive, behavioral, and motor dysfunction. At the pathophysiological level, PTPS is defined by the combination of trauma-induced processes, such as neuroinflammation, axonal injury, and dysregulated acetylation pathways, with mechanisms known to be associated with PD, such as alpha-synuclein aggregation, dopaminergic neuronal loss, and impaired protein clearance. Today, experimental models demonstrate how trauma speeds up or even starts neurodegenerative cascades, providing a unique platform to investigate disease mechanisms outside of the traditional toxin-based paradigms of PD. The current understanding of PD, PTPS, and CTE is summarized in this review, with a focus on risk factors, comparative pathology, and experimental model translational insights. This review emphasizes the significance of acknowledging trauma as more than a trigger but rather as a potential contributor to long-term neurodegeneration and disability by presenting PTPS as a unique but related syndrome within the PD spectrum.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1177/08977151261449702
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
SA, S., NK, G., S, S., RK, G., & SP., S. (2026). Bridging Trauma and Parkinson's Disease: Mechanisms, Models, and Biomarkers of Post-Traumatic Parkinsonism. <em>Journal of neurotrauma</em>. https://doi.org/10.1177/08977151261449702
Vancouver
SA S, NK G, S S, RK G, SP. S. Bridging Trauma and Parkinson's Disease: Mechanisms, Models, and Biomarkers of Post-Traumatic Parkinsonism. Journal of neurotrauma. 2026. doi:10.1177/08977151261449702.
BibTeX
@article{satyaprakash2026Bridgi,
title = {Bridging Trauma and Parkinson's Disease: Mechanisms, Models, and Biomarkers of Post-Traumatic Parkinsonism.},
author = {Satyaprakash SA and Gupta NK and Singh S and Gupta RK and Singh SP.},
journal = {Journal of neurotrauma},
year = {2026},
doi = {10.1177/08977151261449702},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Issues in Molecular Biology 2025
Open access · CC-BY
Protein Misfolding and Aggregation as a Mechanistic Link Between Chronic Pain and Neurodegenerative Diseases
Molecular Neurodegeneration 2010
Open access · CC-BY
Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease
Molecular neurobiology 2026
Citation only
Glymphatic Dysfunction as a Multisystem Pathway Linking Systemic Health Conditions to Alzheimer's Disease: Mechanisms, Risk Factors, and Therapeutic Opportunities.
PubMed 2022
Preprint · OA
[Aggregation and spread of synuclein in Parkinson's disease].
International Journal of Molecular Sciences 2020
Open access · CC-BY
Modeling Neurodegenerative Disorders in Drosophila melanogaster
Applied Sciences 2025
Open access · CC-BY